← Back to Search

Photoacoustic Imaging for Breast Cancer

N/A

Recruiting

Led By Ermelinda Bonaccio

Research Sponsored by Roswell Park Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women with clinically suspicious or confirmed breast cancer masses (that have not been surgically removed) and will/have already undergo/undergone breast magnetic resonance imaging (MRI).

Be older than 18 years old

Must not have

Individuals who are not yet adults (infants, children, teenagers).

Women who have had lumpectomy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 years

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new way to image breasts, which may be especially helpful for women with dense breasts.

Who is the study for?

This trial is for women with suspected or confirmed breast cancer who have not had the mass surgically removed and have undergone or will undergo an MRI. It excludes non-English speakers, prisoners, minors, pregnant women (to avoid unknown risks), those with recent breast implants, and adults unable to consent.

What is being tested?

The study is testing photoacoustic imaging on the breast tissue of both healthy subjects and patients with breast cancer. This technique combines light and sound to potentially improve detection in dense breasts where mammography may be less sensitive.

What are the potential side effects?

There are no direct benefits from participating in this study; however, there are also no known significant side effects associated with photoacoustic imaging as it's a non-invasive procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a breast mass that hasn't been removed and will/have had a breast MRI.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under the age of 18.

Select...

I have had a lumpectomy.

Select...

I understand there's no direct benefit from the study and I speak English.

Select...

I am unable to give consent for medical procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Identify photoacoustic features of breast malignancies

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Diagnostic (photoacoustic imaging of the breast)Experimental Treatment1 Intervention

Participants undergo photoacoustic imaging of the breast over 30 minutes. At subject's discretion, imaging may repeat for a total of 10 studies, each in a separate day.

0 / 5Eligibility criteria met